Molecular DNA testing for FXS, carried out by PCR and Southern blot analysis, showed no PCR amplification and lack of hybridization with the FMR1 specific probe in the proband, indicating the presence of a deletion of the FMR1 gene (Supplementary Figure S1). This evidence concerns the gene FMR1 and fragile X syndrome.